Frequencies for first 10,000 rows of drugcl4 variable in nhamcsed2000 dataset : drug class | for drug #4 | Freq. Percent Cum. ------------+----------------------------------- | 9,040 90.40 90.40 0100 | 1 0.01 90.41 0117 | 9 0.09 90.50 0118 | 2 0.02 90.52 0119 | 27 0.27 90.79 0281 | 3 0.03 90.82 0300 | 1 0.01 90.83 0346 | 16 0.16 90.99 0347 | 22 0.22 91.21 0348 | 18 0.18 91.39 0350 | 2 0.02 91.41 0352 | 4 0.04 91.45 0353 | 5 0.05 91.50 0354 | 1 0.01 91.51 0355 | 11 0.11 91.62 0357 | 16 0.16 91.78 0388 | 8 0.08 91.86 0408 | 11 0.11 91.97 0409 | 24 0.24 92.21 0500 | 1 0.01 92.22 0501 | 3 0.03 92.25 0502 | 4 0.04 92.29 0503 | 11 0.11 92.40 0505 | 3 0.03 92.43 0506 | 8 0.08 92.51 0507 | 12 0.12 92.63 0509 | 2 0.02 92.65 0510 | 12 0.12 92.77 0512 | 9 0.09 92.86 0513 | 6 0.06 92.92 0514 | 15 0.15 93.07 0626 | 5 0.05 93.12 0627 | 17 0.17 93.29 0628 | 8 0.08 93.37 0630 | 20 0.20 93.57 0635 | 11 0.11 93.68 0789 | 1 0.01 93.69 0800 | 1 0.01 93.70 0874 | 54 0.54 94.24 0875 | 5 0.05 94.29 0876 | 9 0.09 94.38 0877 | 11 0.11 94.49 0878 | 6 0.06 94.55 0912 | 9 0.09 94.64 0913 | 16 0.16 94.80 0914 | 6 0.06 94.86 0915 | 36 0.36 95.22 0916 | 1 0.01 95.23 0917 | 1 0.01 95.24 1000 | 1 0.01 95.25 1032 | 32 0.32 95.57 1034 | 7 0.07 95.64 1036 | 17 0.17 95.81 1037 | 6 0.06 95.87 1040 | 1 0.01 95.88 1180 | 11 0.11 95.99 1181 | 1 0.01 96.00 1264 | 6 0.06 96.06 1265 | 6 0.06 96.12 1268 | 10 0.10 96.22 1271 | 4 0.04 96.26 1274 | 3 0.03 96.29 1371 | 6 0.06 96.35 1373 | 8 0.08 96.43 1374 | 20 0.20 96.63 1481 | 1 0.01 96.64 1566 | 2 0.02 96.66 1567 | 1 0.01 96.67 1568 | 1 0.01 96.68 1569 | 1 0.01 96.69 1570 | 1 0.01 96.70 1670 | 1 0.01 96.71 1671 | 19 0.19 96.90 1720 | 2 0.02 96.92 1721 | 78 0.78 97.70 1722 | 62 0.62 98.32 1723 | 1 0.01 98.33 1724 | 48 0.48 98.81 1725 | 1 0.01 98.82 1860 | 1 0.01 98.83 1940 | 43 0.43 99.26 1941 | 7 0.07 99.33 1943 | 16 0.16 99.49 1944 | 15 0.15 99.64 1947 | 3 0.03 99.67 2000 | 2 0.02 99.69 2087 | 31 0.31 100.00 ------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 28 Mar 2016